US Patent 10076512 Treatment of hepatitis delta virus infection
Patent 10076512 was granted and assigned to Eiger BioPharmaceuticals on September, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 26, 2016
Date of Patent
September 18, 2018
Patent Applicant
Patent Application Number
15335327
Patent Citations Received
Patent Inventor Names
Jeffrey S. Glenn
0
Ingrid Choong
0
David A. Cory
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10076512 Treatment of hepatitis delta virus infection
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.